SpineJack System Postmarket Registry
Prospective SpineJack System Registry
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Raffaella Falciglia
- Phone Number: +41326416666
- Email: raffaella.falciglia@stryker.com
Study Contact Backup
- Name: Jessica Ward
- Email: jessica.ward@stryker.com
Study Locations
-
-
California
-
Encinitas, California, United States, 92024
- San Diego Neurosurgery
-
Larkspur, California, United States, 94939
- California Orthopedics and Spine
-
-
Florida
-
Stuart, Florida, United States, 34994
- Cleveland Clinic
-
-
Idaho
-
Boise, Idaho, United States, 83702
- St. Luke's IntermountainResearch Center
-
-
New Hampshire
-
Lebanon, New Hampshire, United States, 03756
- Dartmouth Hitchcock
-
-
New York
-
Bronx, New York, United States, 10467
- Montefiore Medical Center
-
New York, New York, United States, 10029
- Icahn School of Medicine at Mount Sinai
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest Baptist Health
-
-
Oklahoma
-
Edmond, Oklahoma, United States, 73013
- Clinical Investigations
-
-
Washington
-
Puyallup, Washington, United States, 98373
- Center for Diagnostic Imaging (CDI)
-
Puyallup, Washington, United States, 98374
- Rainier Orthopedic Institute
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53226
- Medical College of Wisconsin
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- 18 years of age or older
- Understand and sign the informed consent form (as applicable)
- Exhibit no altered mental status or language barrier that may prevent completion of the patient reported outcome (PRO) surveys following the procedure.
- VCF diagnosis made and/or confirmed at participating site.
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Patients treated with SpineJack system
SpineJack system procedure
|
For use in the reduction of painful osteoporotic vertebral compression fractures.
|
|
Patients treated with vertebral augmentation
Vertebral augmentation procedures may include either balloon kyphoplasty (BKP) or vertebroplasty (VP).
|
Treatment of osteoporotic vertebral compression fractures.
Treatment of osteoporotic vertebral compression fractures.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Back pain
Time Frame: 12 months post-procedure
|
The numeric rating scale consists of an eleven-point scale used for patient self-reporting of back pain, which ranges from 0 (no pain) to 10 (the worst pain imaginable).
|
12 months post-procedure
|
|
Radiological outcomes
Time Frame: Immeditely post-procedure
|
Vertebral body height restoration
|
Immeditely post-procedure
|
|
Radiological outcomes
Time Frame: Immediately post-procedure
|
Adjacent level fractures
|
Immediately post-procedure
|
|
Adverse events
Time Frame: 12 months post-procedure
|
|
12 months post-procedure
|
|
Quality of life indices - Roland Morris Disability Questionnaire (RMDQ)
Time Frame: 12 months post-procedure
|
24-item self-report questionnaire used in patients with mild to moderate disability due to acute, sub-acute or chronic low back pain
|
12 months post-procedure
|
|
Patient-Reported Outcomes Measurement Information System (PROMIS Global-10)
Time Frame: 12 months post-procedure
|
10-item questionnaire that is used to assess general domains of health and functioning, including overall physical health, mental health, social health, pain, fatigue and overall perceived quality of life
|
12 months post-procedure
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- SISSJS2019US
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.